Latest Posts
About This Stock
More About This Stock
Read
Read
Valeant Pharma (VRX) Q3 Earnings Miss, Slashes Guidance
Article By:
Zacks Investment Research
Wednesday, November 9, 2016 6:00 AM EDT
Shares of pharmaceutical company, Valeant Pharmaceuticals Inc. fell over 21% after the company reported disappointing third-quarter 2016 results and slashed its sales and earnings outlook for the year.
Seattle Genetics (SGEN) Loss Narrower Than Expected In Q3
Article By:
Zacks Investment Research
Friday, October 28, 2016 7:13 PM EDT
Seattle Genetics, Inc SGEN reported a loss of 23 cents per share, narrower than the Zacks Consensus Estimate of a loss of 29 cents but wider than the year-ago loss of 21 cents.